Experimental Brain Research

, Volume 147, Issue 2, pp 219–226

Glutamate excess and free radical formation during and following kainic acid-induced status epilepticus

  • Yuto Ueda
  • Hidekatsu Yokoyama
  • Akira Nakajima
  • Jun Tokumaru
  • Taku Doi
  • Yoshio Mitsuyama
Research Article

DOI: 10.1007/s00221-002-1224-4

Cite this article as:
Ueda, Y., Yokoyama, H., Nakajima, A. et al. Exp Brain Res (2002) 147: 219. doi:10.1007/s00221-002-1224-4

Abstract.

Kainic acid (KA) induces seizures and degeneration in CA1 of the ventral hippocampus, though its mechanism of action is unknown. We used KA to induce seizures in freely moving rats prepared for in vivo microdialysis with probe placement, and then measured extracellular glutamate with an online fluorometric detector. Generation of free radicals was monitored by electron paramagnetic resonance (EPR) spectroscopy coupled with perfusion of the spin-trapping agent, α-(4-pyridyl-N-oxide)-N-tert-butylnitrone (POBN). Regional antioxidant efficacy was measured by observing the eliminating ratio of nitroxide radicals, using 3-carbamoyl-2, 2, 5, 5-tetramethylpyrrolidine-1-oxyl (carbamoyl-PROXYL) applied exogenously from the probe. Increased levels of extracellular glutamate observed at the initiation of KA-induced seizures appear to be associated with generation of lipid free radicals and with a decrease in residual antioxidant effects. These data suggest that collapse of the redox state in the hippocampus, the region most vulnerable to injury from seizure activity, may be critical in the regional injury induced by seizures. Further, we propose that the functional failure of glutamate transporters due to oxidative stress results in high levels of extracellular glutamate during sustained generalized seizures induced with KA.

Kainic acid Glutamate Free radicals Antioxidant Microdialysis

Copyright information

© Springer-Verlag 2002

Authors and Affiliations

  • Yuto Ueda
    • 1
  • Hidekatsu Yokoyama
    • 2
  • Akira Nakajima
    • 3
  • Jun Tokumaru
    • 1
  • Taku Doi
    • 1
  • Yoshio Mitsuyama
    • 1
  1. 1.Department of Psychiatry, Miyazaki Medical College, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
  2. 2.Institute for Life Support Technology, Yamagata Public Corporation for Development of Industry, 2–2-1 Matsuei, Yamagata 990-2473, Japan
  3. 3.Department of Chemistry, Miyazaki Medical College, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan